Mark Freedman profile picture

Contact Information

Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
613 737 8917
mfreedman@ohri.ca

Brenda Barasa
bbarasa@toh.ca

News

Common supplement being tested as potential treatment for progressive MS
June 27, 2019 - Lipoic acid (LA), a natural antioxidant, has shown promising results in a small pilot trial in helping people with multiple sclerosis (MS) walk faster and preventing brain atrophy.
Autologous hematopoietic stem cell transplantation recommended as a standard of care for certain kinds of MS in the U.S.
March 13, 2019 - The American Society for Blood and Marrow Transplantation has recommended that stem cell transplantation for MS, which has been pioneered at The Ottawa Hospital, be considered a “standard of care, clinical evidence available” for people with ...
Top Research Papers from The Ottawa Hospital 2015-2017
June 7, 2018 - Did you know that researchers at The Ottawa Hospital publish an average of four new scientific papers every single day? Our research is advancing science and improving health on a massive scale – both at home and around the world. The list below ...
Three Ottawa researchers among “world’s most influential scientific minds”
December 13, 2017 - Drs. Mark Freedman, Jeremy Grimshaw and David Moher were recently ranked among the world’s top 3,300 “most influential scientific minds”. This puts them in the top 0.05 percent of the estimated 7.8 million full-time researchers worldwide. The list,
Common acne medication shows promise in treating multiple sclerosis
June 1, 2017 - Clinical trial shows that minocycline, an oral acne medication, can slow the progress of relapsing-remitting MS A common oral acne medication could provide new, affordable treatment options for Canadians suffering from relapsing-remitting multip
The Ottawa Hospital is leading the way in regenerative medicine
August 30, 2016 - Ten years after the opening of the Sprott Centre for Stem Cell Research, The Ottawa Hospital is playing a lead role in harnessing the power of stem cells to develop new treatments for devastating diseases. Dr. Duncan Stewart explains in this resea
Experimental treatment gave new life to P.E.I. mother
June 15, 2016 - Cathy Nabuurs (far right) took part in an experimental treatment at The Ottawa Hospital for her early, aggressive multiple sclerosis. She and her family – husband, Mike, and their children, Ethan and Megan – saw a major change in her disease.
MS breakthrough: Replacing diseased immune system halts progression and allows repair
June 9, 2016 - Clinical trial suggests chemo and blood stem cell combination therapy should be considered for people with early, aggressive MS A clinical trial published in The Lancet, a top medical journal, shows that an intensive procedure that completely wipe
Tender Loving Research helping people with multiple sclerosis
May 5, 2015 - The latest edition of our Tender Loving Research video blog features Dr. Mark Freedman remembering the patient who first inspired him to specialize in multiple sclerosis research. Dr. Freedman’s research has contributed to the development of several
The Ottawa Hospital leads first Canadian clinical trial of mesenchymal stem cell therapy for multiple sclerosis
January 29, 2015 - The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced today a $4.2 million grant to support the first Canadian clinical trial of mesenchymal stem cell therapy for multiple sclerosis (MS), led by